GeneralConnection.com ➔ Dictionary
Dictionary Search

cholangitis

Synonyms

Noun

1. inflammation

2. redness, rubor

Usage
Seladelpar (Livdelzi) raises the bar for primary biliary cholangitis treatment - 2 Minute Medicine
Early MRCP surveillance for recurrent primary sclerosing cholangitis after liver transplantation: a prospective imaging study - Nature
Treatment Sequencing in Primary Biliary Cholangitis - Medscape Reference
RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis - Science | AAAS
Cholangitis in 2025: Year in Review - HCPLive
Overlap Syndrome Between Autoimmune Hepatitis and Primary Sclerosing Cholangitis in a Seven-Year-Old Child: A Case Report - Cureus
New trial at UC Davis Health shows promising results for rare liver disease - University of California - Davis Health
Oral Vancomycin for IBD and Primary Sclerosing Cholangitis; Stem Cells for CD-Related Fistulas - Gastroenterology & Endoscopy News
Dr. Roach: Know the difference between certain types of cholangitis - The Detroit News
Saroglitazar Boosts Response Rates in Primary Biliary Cholangitis - MedPage Today
FDA Approves Linerixibat for Cholestatic Pruritus in Primary Biliary Cholangitis - The American Journal of Managed Care® (AJMC®)
Protect Your Well-Being With Primary Biliary Cholangitis - Everyday Health
Recent advancements in the development of models to study primary sclerosing cholangitis - News-Medical
An immunobiliary single-cell atlas resolves crosstalk between type 2 conventional dendritic cells and γδ T cells in cholangitis - Nature
Cholangitis: 1 Day of Antibiotics Noninferior to 4-7 Days - Medscape
Shorter Antibiotic Treatment After Adequate Biliary Drainage Non-Inferior in Acute Cholangitis - HCPLive
Addressing the Symptom Burden of Primary Biliary Cholangitis - Medscape Reference
Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation - Nature
The impact of male sex on outcomes in primary biliary cholangitis - Nature
Vitamin D3 attenuates hepatic inflammation in primary biliary cholangitis by inhibiting TLR4/NF-κB mediated M1 macrophage polarization | Scientific Reports - Nature
NICE approves seladelpar for primary biliary cholangitis - The Pharmaceutical Journal
Volixibat Soothed the Itch in Primary Sclerosing Cholangitis - MedPage Today
Pembrolizumab-Induced Secondary Cholangitis: A Case Report - Cureus
Tailoring Empirical Antibiotics in Acute Cholangitis - EMJ
Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Diagnostic Challenge in a Sri Lankan Patient - Cureus
Integrative multi-omics and causal inference unveil novel therapeutic targets for primary sclerosing cholangitis and its genetic comorbidity with inflammatory bowel disease - Nature
Fenofibrate-UDCA Combination Therapy Safe and Effective for Primary Biliary Cholangitis - Cleveland Clinic
FDA Grants Priority Review to Saroglitazar NDA for Primary Biliary Cholangitis - HCPLive
Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the Forecast Period (2025-2034) | DelveInsight - PR Newswire
Lipidomic characterization of bile and serum reveals an altered lipid landscape in end-stage primary sclerosing cholangitis - Nature
Exploring primary biliary cholangitis - Healio
Diagnostic potential of salivary biomarkers for primary biliary cholangitis: a systematic review - Frontiers
Treating primary biliary cholangitis - Mayo Clinic Press
Intraductal Papillary Neoplasm With Associated Invasive Cholangiocarcinoma and Biliary Intraepithelial Neoplasia in Primary Sclerosing Cholangitis: A Case Report - Cureus
Case Report: The complete radiological resolution of diffuse cholangitis in a HIV-positive patient with cryptosporidium infection after anti-retroviral therapy - Frontiers
Gilead’s Livdelzi® (Seladelpar) Delivers Statistically Significant Composite ALP Normalization in Phase 3 IDEAL Trial in Primary Biliary Cholangitis (PBC) - Yahoo Finance
FDA Approves Linerixibat for Cholestatic Pruritus in Primary Biliary Cholangitis - Pharmacy Times
Statin Use Linked to Lower Hepatic Decompensation Risk in Primary Biliary Cholangitis - Medscape
Bezafibrate for primary biliary cholangitis: time to act on the evidence - Nature
Sump syndrome following hepaticojejunostomy: a case report of IgG4-related sclerosing cholangitis - Frontiers
Clinicopathological features of non-cirrhotic portal fibrosis in primary biliary cholangitis: A 15-year experience at a tertiary referral center - Frontiers
68Ga-FAPI-46 PET/CT in Primary Sclerosing Cholangitis and Suspected Cholangiocarcinoma - Journal of Nuclear Medicine
Molecular mechanisms underlying T cell subset imbalance and precision therapeutic targets in primary biliary cholangitis - Frontiers
Primary Sclerosing Cholangitis and Ulcerative Colitis: What to Know About This Liver Complication - Everyday Health
Reduction of Antibiotic Course After Biliary Drainage - Docwire News
Seladelpar reduced pruritus in PBC as early as ‘first month, and persisted’ - Healio
Eosinophilic cholangitis misdiagnosed as cholangiocarcinoma: a case report - Frontiers
Beyond tired: Understanding fatigue in Primary Biliary Cholangitis - Ipsen
Gilead's Livdelzi scores in rare liver disease trial, portending use in broader patient population - Fierce Pharma
Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA - PR Newswire
Quality of Life Remains Stable in Autoimmune Liver Disease - EMJ
A multi-omics and machine learning framework identifies plasma SBDS as a causal biomarker and therapeutic target in primary sclerosing cholangitis - EurekAlert!
Blood group A linked to a higher risk of primary biliary cholangitis - News-Medical
Elafibranor Shows Promise for Primary Sclerosing Cholangitis - EMJ
Primary biliary cholangitis–associated osteoporosis: contemporary review of pathogenesis and management - EurekAlert!
Seladelpar Staves Off Liver Stiffness in PBC - Medscape
Acute cholangitis: ERCP within 24 hours offers no mortality benefit over 24–48 hours - Vera Health
A Complex Case of Acalculous Cholecystitis, Cholangitis, and Pancreatitis Managed With Percutaneous Cholecystostomy in a Septic Patient - Cureus
Your Good Health: Know the difference between certain types of cholangitis - Times Colonist
Gilead fashions new primary biliary cholangitis campaign alongside 'Project Runway' designer - Fierce Pharma
Methylene Blue for Refractory Shock Due to Acute Pancreatitis and Cholangitis - Cureus
LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC) - PR Newswire
Beyond Ursodeoxycholic Acid: A Comprehensive Review of Second-Line Agents in Primary Biliary Cholangitis - Cureus
Sustained abnormal bilirubin and leukocyte levels after ERCP with acute suppurative obstructive cholangitis: a case report with 2 months follow-up observation - Frontiers
MRI scans catch early signs of PSC recurrence after liver transplant - Liver Disease News
Genetic analysis unveils 3 potentially key treatment targets for PSC - Liver Disease News
Mayo Clinic study sheds light on colorectal cancer risk in overlooked group - Mayo Clinic News Network
Rectify Pharmaceuticals Presents New Translational Data at - GlobeNewswire
Journal of Internal Medicine - Wiley Online Library
Ocaliva for PBC Withdrawn From US Market - Medscape
An experimental study on the effect of symptom expectations on mental fatigue and motivation in people with primary biliary cholangitis - Nature
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026 - Yahoo Finance
Navigating Primary Biliary Cholangitis in Singapore: Addressing the Diagnostic Gap and the Next-Generation Therapies - The Manila Times
Alfasigma bets up to $690M on GSK’s late-stage PBC itch drug ahead of FDA decision - European Biotechnology Magazine
Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis - PR Newswire
Low Phospholipid-Associated Cholelithiasis Syndrome: A Case Report of Chronic Recurrent Cholangitis Post-Cholecystectomy Course - Wiley Online Library
Research progress and perspectives of non-coding RNAs in primary biliary cholangitis: from mechanisms to therapeutics - Frontiers
PBC worst for life quality among autoimmune liver diseases: Study - Liver Disease News
From Stent to Septic shock: A Rare Case of Tumor Ingrowth Through an Uncovered Self-Expandable Metal Stent Causing Life-Threatening Cholangitis in Pancreatic Head Carcinoma - Cureus
COUR Pharma Announces Positive One-Year Results from the - GlobeNewswire
Intercept Announces Voluntary Withdrawal of OCALIVA® for - GlobeNewswire
Interim Data Support Elafibranor in Rare Chronic Liver Disease - MedPage Today
After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease - Fierce Pharma
Immunotherapy-Induced Hepatitis Mimicking Sclerosing Cholangitis in a Patient With Metastatic Triple-Negative Breast Cancer - Cureus
Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision - MedCity News
IBD and PSC: Shifting perspectives after colectomy and liver transplantation - EurekAlert!
Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta - Slideshow (NASDAQ:MIRM) 2026-05-06 - Seeking Alpha
New trial testing probiotic for reducing liver inflammation in PSC - Liver Disease News
The Role of Expectations in Primary Biliary Cholangitis Fatigue - EMJ
From dive trips to a transplant: One woman’s battle with a rare autoimmune liver disease - CNA Lifestyle
Phase 2 trial of volixibat for PSC-related itching now fully enrolled - Liver Disease News
September's PBC Awareness Month raises support for a rare liver disease - Liver Disease News
NICE recommends Ipsen’s IQIRVO® (elafibranor) – the first medicine approved for NHS use in nearly a decade for primary biliary cholangitis (PBC), a rare liver disease - Ipsen
Colorectal cancer risk higher in PSC even without inflammatory bowel disease - Liver Disease News
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis - The New England Journal of Medicine
Liver Disease Drug Pulled From the Market - MedPage Today
LYVDELZI® (SELADELPAR) RECEIVES HEALTH CANADA APPROVAL FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS - Newswire Canada
T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis - Nature
Large study finds risks of liver cancer low for certain PSC patients - Liver Disease News
Risk prediction of cholangitis after stent implantation based on machine learning - Nature
Foreign Language Equivalents
Foreign Language Equivalents of 'cholangitis'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
cholagitis,   chloangitis,   chlangitis,   cholangiis,   cholangiris,   cholangitiis,   cholangitia,   ccholangitis,   cholangtis,   vholangitis,   chholangitis,   cho;angitis,   xholangitis,   cholamgitis,   cholanitis,   chilangitis,   cholangitiss,   cholangotis,   cholangiitis,   chollangitis,   colangitis,   cholangutis,   cholaangitis,   cholangtiis,   cholnagitis,   cohlangitis,   chplangitis,   cholanigtis,   cholanngitis,   cholagnitis,   holangitis,   cgolangitis,   cholangits,   cholangitsi,   cjolangitis,   cholangitus,   hcolangitis,   cholanfitis,   cholangitos,   choalngitis,   cholngitis,   cholanggitis,   cholangiyis,   cholabgitis,   cholangitid,   cholangiti,   chokangitis,   choangitis,   cholanhitis,   choolangitis,   cholangiits,   cholsngitis,   cholangittis
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z